Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice (Q46097849)

19 December 2017

title

Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice (English)

1 reference

19 December 2017

1 reference

Lactobacillus fermentum

object named as

Lactobacillus fermentum

1 reference

Josep Mañé

1 reference

19 December 2017

Violeta Lorén

1 reference

19 December 2017

Elisabet Pedrosa

1 reference

19 December 2017

Isabel Ojanguren

1 reference

19 December 2017

Jordi Xaus

1 reference

19 December 2017

Eduard Cabré

1 reference

19 December 2017

Eugeni Domènech

1 reference

19 December 2017

Miquel A Gassull

1 reference

19 December 2017

publication date

1 August 2009

1 reference

19 December 2017

Inflammatory Bowel Diseases

published in

1 reference

19 December 2017

volume

1 reference

19 December 2017

issue

1 reference

19 December 2017

page(s)

1155-1163

1 reference

19 December 2017

Dysbiosis in inflammatory bowel disease

cites work

1 reference

Mucosal flora in inflammatory bowel disease

21 January 2018

1 reference

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

21 January 2018

1 reference

Crohn's disease: a defensin deficiency syndrome?

21 January 2018

1 reference

Probiotics and the management of inflammatory bowel disease.

21 January 2018

1 reference

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

21 January 2018

1 reference

Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.

21 January 2018

1 reference

Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis

21 January 2018

1 reference

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

21 January 2018

1 reference

The normal Lactobacillus flora of healthy human rectal and oral mucosa.

21 January 2018

1 reference

Immunity, inflammation, and allergy in the gut.

21 January 2018

1 reference

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

21 January 2018

1 reference

Lactobacillus fermentum ACA-DC 179 displays probiotic potential in vitro and protects against trinitrobenzene sulfonic acid (TNBS)-induced colitis and Salmonella infection in murine models

21 January 2018

1 reference

Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model

21 January 2018

1 reference

Aggravating effect of cigarette smoke exposure on experimental colitis is associated with leukotriene B(4) and reactive oxygen metabolites.

21 January 2018

1 reference

5-Lipoxygenase modulates colitis through the regulation of adhesion molecule expression and neutrophil migration

21 January 2018

1 reference

Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation

21 January 2018

1 reference

Prostanoids in immunity: Roles revealed by mice deficient in their receptors

21 January 2018

1 reference

Prostanoid receptors in intestinal epithelium: selective expression, function, and change with inflammation

21 January 2018

1 reference

Lactobacillus acidophilus protects tight junctions from aspirin damage in HT-29 cells

21 January 2018

1 reference

Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine.

21 January 2018

1 reference

Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis.

21 January 2018

1 reference

Naturally arising CD4+CD25+ regulatory T cells suppress the expansion of colitogenic CD4+CD44highCD62L- effector memory T cells

21 January 2018

1 reference

Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25 T cells via p53, IL-2, and OX40

21 January 2018

1 reference

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

21 January 2018

1 reference

Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats.

21 January 2018

1 reference

Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer

21 January 2018

1 reference

Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance

21 January 2018

1 reference

Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

21 January 2018

1 reference

Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways

21 January 2018

1 reference

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

21 January 2018

1 reference

What does it mean to be just 17?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.20908

1 reference

19 December 2017

1 reference

19 December 2017